Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
September 30, 2026 20.30M
June 30, 2026 12.29M
March 31, 2026 0.00
December 31, 2025 6.403M
September 30, 2025 2.728M
June 30, 2025 6.324M
March 31, 2025 3.151M
December 31, 2024 1.810M
September 30, 2024 2.583M
June 30, 2024 0.0352M
March 31, 2024 0.316M
December 31, 2023 0.00
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.00
December 31, 2021 1.213M
September 30, 2021 42.83M
June 30, 2021 1.784M
March 31, 2021 3.675M
December 31, 2020 0.0136M
September 30, 2020 -9.398M
Date Value
June 30, 2020 4.472M
March 31, 2020 6.113M
December 31, 2019 0.1296M
September 30, 2019 2.016M
June 30, 2019 0.1088M
March 31, 2019 0.161M
December 31, 2018 -0.2324M
September 30, 2018 -0.203M
June 30, 2018 34.47M
March 31, 2018 0.00
December 31, 2017 0.026M
September 30, 2017 54.16M
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015 -0.6003M
September 30, 2015 30.98M
June 30, 2015 1.628M
March 31, 2015 0.00
December 31, 2014 4.346M
September 30, 2014 -0.0023M
June 30, 2014 0.0015M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Cypherpunk Technologies, Inc. 57.26M
Capricor Therapeutics, Inc. 0.0887M
Ocugen, Inc. 0.161M
Cue Biopharma, Inc. 50.63M
Yarrow Bioscience, Inc. 265.03M